OrganMini 3D volumetric bioprinter

텍스트를 입력해주세요

Anti-CT projection printing technology

This technology features non-contact and ultra-fast printing capabilities, overcoming the issues of slow printing speed and low cell survival rate associated with traditional contact bioprinters. Additionally, it is easy and quick to operate, with one-step molding, enabling the acquisition of centimeter-scale, highly viable three-dimensional tissues in just one minute.

High viability, High expression

The entire printing process takes place in a sealed printing bottle, utilizing visible light curing for integrated molding, rather than UV curing. It boasts fast printing speeds, no contact damage, no pollution, ensuring that the printed cell models maintain a cell survival rate of over 95% and a high expression levels*.

*Bernal et al. Advanced materials 2022  

High-precision printing of structures

OrganMini employs a projection printing principle akin to "creating objects out of thin air", eliminating the need for supports or scaffolds to produce intricate three-dimensional models of complex structures such as microvessels, C60, skin, ears, and more. It also facilitates the simultaneous custom printing of multiple three-dimensional models. 

*MB Xie, et al. Nature Communications, 2023

"One-click printing" software

We have specially designed the Haomiao printing software for OrganMini, which supports multi-user management. The software allows for fine adjustments of parameters such as position, rotation, size, light intensity, duration, and rotation speed. Additionally, the software comes pre-installed with a library of over 200 commonly used models to meet various needs.

 

Organoid construction leading solution

OrganMini boasts three core technologmicrospheres, eliminating the significant batch-to-batch variability inherent in manual

 operations; Clinical validation has shown that this technological breakthroughs: 60-second ultra-fast integrated printing, which

 supports the simultaneous printing of multiple organoid y can shorten the organoid construction cycle to 7-14 days, with a drug

 screening accuracy rate of 83.3%.

 

Disruptive technology

Case1:The article exploring the mechanism by which ENO2 desensitizes colorectal cancer drugs has been published in Nature Metabolism。 Case2:Exploring the combination of pure silk fibroin ink and volumetric bioprinting, the article has been published in Nature Communication。 Case3:Exploring the relationship between decellularized extracellular matrix (dECM) and volumetric bioprinting, the article has been published in Advanced materials。  

 
General
Nane3D volumetric bioprinter/3D material preparation instrument
Dimensions of imaging host460mm×270mm×320mm
Weight of imaging host13kg
Technical parameters
Printing Time10-120s
Model Cell Viability>95%
Printing Resolution50-300μm
Printing Size5-20mm
Printing PrincipleReverse CT Projection,One-step Forming, Support-free, Contactless
Printed Model Size≥1mm±0.5mm×1mm±0.5mm×1mm±0.5mm
Light SourceLED Visible Light Source with No Less Than Three Wavelength Bands
Wavelength385nm or 405nm or Visible Light RGB (460nm,523nm,635nm)
Model LibraryBuilt-in Model Library with 200+ Common Models
Featured FunctionsMulti-user Management Function: Organ Mini Features Embedded Slicing(Software Supports Self-slicing of User-created 3D Models)
Item number
3D volumetric bioprinter/3D material preparation instrumentT200(Host Machine, 5g Bioink, 1 Bottle of Photoinitiator, 1 Viability Analysi.Device)
OrganMini(Host Machine, 50g Bioink, 10 Bottles of Photoinitiator, 1 ViabilityAnalysis Device)